Longitudinal continuous glucose monitoring system market data indicates that the adoption rate among Type 1 diabetics has already surpassed 50% in developed countries. The next "frontier" for the industry is the much larger Type 2 population, where adoption is currently below 10%. Statistical models suggest that if even a quarter of Type 2 patients adopt CGM technology, the market volume would...